| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.799 | 4.454 | 1.532 | 9.993 | 10.864 | 28.206 | 72.367 | 320.418 | 629.360 | 392.141 |
| Total Income - EUR | 10.799 | 6.903 | 1.533 | 10.012 | 11.081 | 28.940 | 72.409 | 324.777 | 629.555 | 482.593 |
| Total Expenses - EUR | 4.947 | 5.333 | 1.408 | 4.034 | 2.247 | 27.854 | 127.627 | 243.480 | 426.339 | 468.926 |
| Gross Profit/Loss - EUR | 5.852 | 1.570 | 125 | 5.979 | 8.834 | 1.086 | -55.219 | 81.296 | 203.216 | 13.667 |
| Net Profit/Loss - EUR | 5.528 | 1.363 | 79 | 5.679 | 8.508 | 798 | -55.942 | 78.252 | 190.716 | 10.483 |
| Employees | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 4 |
Check the financial reports for the company - Crn - Clinical Research Network S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 834 | 826 | 770 | 756 | 0 | 0 | 2.201 | 1.227 | 41.779 | 162.799 |
| Current Assets | 4.739 | 5.692 | 7.130 | 13.522 | 21.649 | 22.546 | 24.533 | 104.798 | 295.796 | 213.619 |
| Inventories | 966 | 956 | 940 | 0 | 0 | 0 | 0 | 0 | 0 | 3.007 |
| Receivables | 298 | 4.454 | 5.911 | 6.730 | 4.718 | 4.341 | 3.029 | 44.287 | 267.807 | 210.572 |
| Cash | 3.475 | 282 | 280 | 6.793 | 16.931 | 18.204 | 21.504 | 60.511 | 27.989 | 40 |
| Shareholders Funds | 5.573 | 3.705 | 3.634 | 9.246 | 17.575 | 18.040 | -38.302 | 39.832 | 230.427 | 228.696 |
| Social Capital | 45 | 178 | 88 | 86 | 84 | 83 | 81 | 81 | 81 | 80 |
| Debts | 0 | 2.813 | 4.266 | 5.032 | 4.074 | 4.562 | 73.826 | 66.248 | 110.724 | 151.734 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Crn - Clinical Research Network S.r.l.